Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial by Cruz, Leticia R, Baladrón, Idania, Rittoles, Aliusha, Díaz, Pablo A, Valenzuela, Carmen, Santana, Raúl, Vázquez, Maria M, García, Ariadna, Chacón, Deyli, Thompson, Delvin, Perera, Gustavo, González, Ariel, Reyes, Rafael, Torres, Loida, Pérez, Jesus, Valido, Yania, Rodriguez, Ralysmay, Vázquez-Bloomquist, Dania M, Rosales, Mauro, Ramón, Ailyn C, Pérez, George V, Guillén, Gerardo, Muzio, Verena, Perera, Yasser, Perea, Silvio E

Get full text